Biotest Aktiengesellschaft Stock Net Income

BIESFDelisted Stock  USD 32.00  0.00  0.00%   
Fundamental analysis of Biotest Aktiengesellscha allows traders to better anticipate movements in Biotest Aktiengesellscha's stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Biotest Aktiengesellschaft Company Net Income Analysis

Biotest Aktiengesellscha's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Biotest Aktiengesellscha Net Income

    
  (63.4 M)  
Most of Biotest Aktiengesellscha's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotest Aktiengesellschaft is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Biotest Aktiengesellschaft reported net income of (63.4 Million). This is 118.58% lower than that of the Healthcare sector and 190.51% lower than that of the Biotechnology industry. The net income for all United States stocks is 111.1% higher than that of the company.

Biotest Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotest Aktiengesellscha's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotest Aktiengesellscha could also be used in its relative valuation, which is a method of valuing Biotest Aktiengesellscha by comparing valuation metrics of similar companies.
Biotest Aktiengesellscha is currently under evaluation in net income category among its peers.

Biotest Fundamentals

About Biotest Aktiengesellscha Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Biotest Aktiengesellschaft's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotest Aktiengesellscha using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotest Aktiengesellschaft based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Biotest Pink Sheet

If you are still planning to invest in Biotest Aktiengesellscha check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotest Aktiengesellscha's history and understand the potential risks before investing.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing